The latest price target for Compugen (NASDAQ:CGEN) was reported by Truist Securities on May 21, 2024. The analyst firm set a price target for $4.00 expecting CGEN to rise to within 12 months (a possible 166.67% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Compugen (NASDAQ:CGEN) was provided by Truist Securities, and Compugen maintained their buy rating.

There is no last upgrade for Compugen

The last downgrade for Compugen Ltd happened on February 8, 2023 when Jefferies changed their price target from N/A to $0.5 for Compugen Ltd.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Compugen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Compugen was filed on May 21, 2024 so you should expect the next rating to be made available sometime around May 21, 2025.

While ratings are subjective and will change, the latest Compugen (CGEN) rating was a maintained with a price target of $5.00 to $4.00. The current price Compugen (CGEN) is trading at is $1.50, which is out of the analyst’s predicted range.